Company Monitoring Page for Ultragenyx

latest headlines for company on cafepharma

Crysvita sales push Ultragenyx ahead for the quarter
BioCentury
Fri, 08/2/19 - 12:24 am
Tags:
Ultragenyx, Crysvita, earnings
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
Tags:
biotech, earnings, Immunic, Alkermes, Conatus, Aevi Genomic, Tricida, Curis, Ultragenyx, Leap Therapeutics, Cidara Therapeutics, Akcea, Spark Therapeutics, Eli Lilly, AnaptysBio, clinical trials
Ultragenyx close to learning whether gene therapy gamble will pay off
Biopharma Dive
Fri, 07/19/19 - 12:51 pm
Tags:
Ultragenyx, Dimension Therapeutics, gene therapy, DTX-301, DTX-401
A former failure in PhII, the go-go FDA says it’s ready to consider an accelerated shortcut for Ultragenyx’s UX007
Endpoints
Wed, 08/29/18 - 10:41 am
Tags:
Ultragenyx, UX007, FDA, LC-FAOD
After FDA Approves Bone Disease Drug, Ultragenyx Sets $200K Price
Xconomy
Tue, 04/17/18 - 09:55 pm
Tags:
Ultragenyx, FDA, X-linked hypophosphatemia
What’s the big hurry Novartis? Pharma giant scores a PRV shortcut for $130M
Endpoints
Mon, 12/18/17 - 10:02 am
Tags:
Novartis, priority review vouchers, Ultragenyx
UltraGenyx wins first drug approval, valuable PRV
BioPharma Dive
Thu, 11/16/17 - 07:17 pm
Tags:
Ultragenyx, FDA, priority review, Mepsevii, Sly Syndrome
Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal
Endpoints
Mon, 09/18/17 - 09:26 am
Tags:
Dimension Therapeutics, Ultragenyx, Regenxbio, gene therapy, R&D
Ultragenyx shelves genetic disease drug after trial failure
BioPharma Dive
Wed, 08/23/17 - 10:08 pm
Tags:
Ultragenyx, clinical trials, Ace-ER
Positive results help Ultragenyx recover after prior failure
BioPharma Dive
Thu, 04/20/17 - 09:49 am
Tags:
Ultragenyx, KRN23, burosumab, hypophosphatemia
Ultragenyx shares tumble lower after rare disease drug fails PhII trial
Endpoints
Thu, 03/23/17 - 09:24 am
Tags:
Ultragenyx, clinical trials, UX007, Glut1 DS
These 15 Biotech Companies Could Be Takeover Targets
Barron's
Wed, 06/29/16 - 12:56 pm
Tags:
biotech, M&A, Alder Biopharmaceuticals, Biomarin, Coherus Biosciences, Intercept Pharma, Ultragenyx, Seattle Genetics, Adamas Pharmaceuticals, Alexion, Clovis Oncology, Corbus Pharmaceuticals, Incyte, Prothena, Puma Biotechnology, Tesaro, Versartis
8 Major Biopharma Events Coming Later in 2016 and in 2017
24/7 Wall St
Tue, 03/29/16 - 10:32 pm
Tags:
Vertex Pharmaceuticals, VX-661, cystic fibrosis, Incyte, ruxolitinib, colorectal cancer, breast cancer, Ultragenyx, KRN23, osteomalacia, GW Pharma, Epidiolex, Puma Biotechnology, neratinib, Celator Pharmaceuticals, Vyxeos, Biocryst, OPuS-2, BCX7353, HAE, Galena Biopharma, NeuVax, trastuzumab
8 Biotech Stocks That Have a ‘Greater Probability’ of Being Acquired
Barron's
Tue, 03/29/16 - 12:24 pm
Tags:
biotech, M&A, Ardelyx, Ophthotech, Medivation, Puma Biotechnology, Ultragenyx, Portola Pharmaceuticals, Versartis, Relypsa
Sanofi scouts for rare disease buyouts as Shire bears down on the field
Fierce Biotech
Tue, 03/1/16 - 09:37 am
Tags:
Sanofi, Shire, M&A, R&D, Biomarin, Ionis Pharmaceuticals, Ultragenyx
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Wed, 01/14/15 - 10:00 am
Tags:
Shire, M&A, PTC Therapeutics, SynaGeva BioPharma, Retrophin, Ultragenyx, Vertex Pharmaceuticals, Biomarin
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
Tags:
biotech, Threshold Pharmaceuticals, Acceleron, Spectrum Pharmaceuticals, Ultragenyx, Argos Therapeutics, OncoMed, Peregrine Pharmaceuticals, Incyte, Calithera, Array Biopharma, Theravance, Puma Biotechnology, CTI BioPharma, Orexigen, Enanta Pharmaceuticals, Sucampo, Exelixis, Cubist Pharmaceuticals, United Therapeutics
Ultragenyx Reports Data from Sialic Acid Deficiency Study
Yahoo/Zacks
Sat, 10/18/14 - 10:03 am
Tags:
Ultragenyx, SA-ER, hereditary inclusion body myopathy
2014's most successful biotech IPOs
Fierce Biotech
Mon, 10/13/14 - 08:03 am
Tags:
IPOs, biotech, Ultragenyx, ZS Pharma, Auspex Pharmaceuticals, Avalanche Biotechnologies, SAGE Therapeutics, Kite Pharma, Otonomy, Zafgen, ProQR, Radius Health
3 Biotech Stocks Breaking Out on Big Volume
TheStreet.com
Mon, 07/21/14 - 10:36 am
Tags:
Ultragenyx, Bluebird Bio, Immunogen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.